GB1286351A - Oxytetracycline solutions containing polyethylene glycols - Google Patents

Oxytetracycline solutions containing polyethylene glycols

Info

Publication number
GB1286351A
GB1286351A GB3700770A GB3700770A GB1286351A GB 1286351 A GB1286351 A GB 1286351A GB 3700770 A GB3700770 A GB 3700770A GB 3700770 A GB3700770 A GB 3700770A GB 1286351 A GB1286351 A GB 1286351A
Authority
GB
United Kingdom
Prior art keywords
oxytetracycline
polyethylene glycols
solutions containing
polyethylene glycol
containing polyethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3700770A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of GB1286351A publication Critical patent/GB1286351A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB3700770A 1970-01-15 1970-07-30 Oxytetracycline solutions containing polyethylene glycols Expired GB1286351A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702001604 DE2001604C2 (de) 1970-01-15 1970-01-15 Verwendung von Polyäthylenglykol zur Herstellung von Oxytetracyclinlösungen zur parenteralen, peroralen und lokalen Anwendung

Publications (1)

Publication Number Publication Date
GB1286351A true GB1286351A (en) 1972-08-23

Family

ID=5759662

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3700770A Expired GB1286351A (en) 1970-01-15 1970-07-30 Oxytetracycline solutions containing polyethylene glycols

Country Status (4)

Country Link
JP (1) JPS4935410B1 (de)
DE (1) DE2001604C2 (de)
FR (1) FR2081434B1 (de)
GB (1) GB1286351A (de)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007130848A2 (en) * 2006-05-03 2007-11-15 Warsaw Orthopedic, Inc Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
WO2007147133A1 (en) * 2006-06-15 2007-12-21 Serenex, Inc. Stabilized tetracycline compositions
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US8153112B2 (en) 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US8956667B2 (en) 2009-03-26 2015-02-17 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
US9078808B2 (en) 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
US9244060B2 (en) 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US9597352B2 (en) 2005-05-31 2017-03-21 Warsaw Orthopedic, Inc. Compositions and methods for treating pain
US9675696B2 (en) 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
GB9413873D0 (en) * 1994-07-09 1994-08-31 Norbrook Lab Ltd Long-acting oxytetracycline composition
US6110905A (en) * 1994-07-09 2000-08-29 Norbrook Laboratories Limited Long-acting oxytetracycline composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597352B2 (en) 2005-05-31 2017-03-21 Warsaw Orthopedic, Inc. Compositions and methods for treating pain
AU2007248226B2 (en) * 2006-05-03 2012-11-08 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
WO2007130848A3 (en) * 2006-05-03 2008-01-24 Warsaw Orthopedic Inc Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
JP2009535416A (ja) * 2006-05-03 2009-10-01 ウォーソー・オーソペディック・インコーポレーテッド 神経損傷の処置のためのバイオメンブレンシーリング剤を含む組成物、および使用の方法
JP2014074061A (ja) * 2006-05-03 2014-04-24 Warsaw Orthopaedic Inc 神経損傷の処置のためのバイオメンブレンシーリング剤を含む組成物、および使用の方法
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US9950005B2 (en) 2006-05-03 2018-04-24 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
WO2007130848A2 (en) * 2006-05-03 2007-11-15 Warsaw Orthopedic, Inc Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8945623B2 (en) 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US9717756B2 (en) 2006-05-03 2017-08-01 Warsaw Orthopedic, Inc. Method of treating traumatic brain or spinal cord injury with biomembrane sealing agent and magnesium compounds
WO2007147133A1 (en) * 2006-06-15 2007-12-21 Serenex, Inc. Stabilized tetracycline compositions
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US9452183B2 (en) 2009-03-26 2016-09-27 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US9486478B2 (en) 2009-03-26 2016-11-08 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US9244060B2 (en) 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US9078808B2 (en) 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
US8956667B2 (en) 2009-03-26 2015-02-17 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US10883976B2 (en) 2009-03-26 2021-01-05 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions

Also Published As

Publication number Publication date
FR2081434A1 (de) 1971-12-03
DE2001604C2 (de) 1983-04-14
DE2001604A1 (de) 1971-08-19
JPS4935410B1 (de) 1974-09-21
FR2081434B1 (de) 1974-08-30

Similar Documents

Publication Publication Date Title
GB1286351A (en) Oxytetracycline solutions containing polyethylene glycols
GB1211811A (en) Process for the preparation of polyurethanes
ES397353A1 (es) Un procedimiento para la preparacion de soluciones acuosas de bajo contenido en iones metalicos libres.
GB1269908A (en) Amino acids having anti-viral effects
GB1374979A (en) 3,5-dioxopiperazine derivatives
ES421313A1 (es) Procedimiento para la preparacion de compuestos de inclu- sion molecular a base de un complejo de plata-alcanolamina ycicloheptaamilosa.
GB1262785A (en) Improvements in or relating to phloroglucinol derivatives
GB1383939A (en) Battery electrolyte composition
GB1386150A (en) 6-acylaminophenyl-4,5-dihydropyridazones
ES388577A1 (es) Procedimiento para el sellado de superficies de aluminio anonizado.
GB1177429A (en) Filter Dyes
GB1346544A (en) Silver allantoinate-containing compositions
GB1428945A (en) Sweetening compositions
GB1374294A (en) 2-amino-methylphenols
GB1427882A (en) Oxytetracycline solutions
ES427653A1 (es) Procedimiento para la preparacion de nuevos acidos 3-hidro- xiacilaminometil-5-acilamino-2, 4, 6-triyodo-benzoicos.
GB1346812A (en) Photographic processing composition
GB1313228A (en) Tri-iodo-benzoic acid derivatives
ES386969A1 (es) Un metodo para preparar una amidinourea.
GB1449146A (en) Prostaglandins and the preparation thereof
GB1362276A (en) Stable lactone solution
ES416971A1 (es) Procedimiento para la preparacion de derivados isoquinoli- na.
GB1271519A (en) Improvements in or relating to derivatives of phloroglucinol
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
ES386553A1 (es) Procedimiento de preparacion de un nuevo derivado papavero-linico.

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years